Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 2, 2007, Pages 270-276

  Sill, Michelle L ^a   Law, Dennis K S ^a   Zhou, Jianwei ^a   Skinner, Stuart ^b   Wylie, John ^c   Tsang, Raymond S W ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

Antibiotic susceptibility; Genetics; Invasive H. influenzae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; MOXIFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CLONAL VARIATION; CONTROLLED STUDY; ENZYME SYNTHESIS; HAEMOPHILUS INFLUENZAE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; SEROTYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MANITOBA; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA; SEROTYPING;

EID: 35148818301     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00299.x     Document Type: Article

References (29)

1. Bajanca P, Canica M The Multicenter Study Group (2004) Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989-2001). J Clin Microbiol 42 : 807 810.
2. Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N Ohuabunwo C (2002) Progress towards elimination of Haemophilus influenzae type b invasive disease among infants and children - United States, 1998-2000. MMWR 51 : 234 237.
3. Branefors-Helander P, Erbing C, Kenne L Linberg R (1977) The structure of the capsular antigen from Haemophilus influenzae type a. Carbohydr Res 56 : 117 122.
4. Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, Lazaro E, de Abajo F The Group of Invasive Haemophilus infections of the Autonomous Community of Madrid, Spain (2004) Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol 42 : 524 529.
5. Cerquetti M, Ciofi degli Atti ML, Renna G, Tozzi AE, Garlaschi ML, Mastrantonio P The Hi Study Group (2000) Characterization of non-type b Haemophilus influenzae strains isolated from patients with invasive disease. J Clin Microbiol 38 : 4649 4652.
6. Chin Cl, Manzel LJm Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S Look DC (2005) Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 172 : 85 91.
7. Crisel RM, Baker RS Dorman DE (1975) Capsular polymer of Haemophilus influenzae, type b. J Biol Chem 250 : 4926 4930.
8. Falla TJ, Dobson SRM, Crook DWM, Kraak WAG, Nichols WW, Anderson BC, Jordens JZ, Slack MPE, White DM Moxon ER (1993) Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet 341 : 851 854.
9. Falla TJ, Crook DWM, Brophy LN, Maskell D, Kroll JS Moxon ER (1994) PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 32 : 2382 2386.
10. Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS Doern GV (2005) Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother 49 : 2561 2564.
11. Jordens RN Slack MPE (1995) Haemophilus influenzae: then and now (a review). Eur J Clin Microbiol Infect Dis 14 : 935 948.
12. Karpanoja P, Nissinea A, Huovinen P Sarkkinen H (2004) Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs. J Antimicrob Chemother 53 : 660 663.
13. Kilian M (1976) A taxonimic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol 93 : 9 62.
14. Kilian M (2003) Haemophilus. Manual of Clinical Microbiology, 8th edn (Murray PR, Baron EJ, Jorgensen JH, Pfaller MA Yolken RH, eds), pp. 623 635. ASM Press, Washington, DC.
15. Kroll JS, Zamze S, Loynds B Moxon ER (1989) Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol 171 : 3343 3347.
16. Makela PH, Peltola H, Kaythy H et al 1977) Polysaccharide vaccines of group a Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 136 (suppl), S43 S50.
17. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, Popovic T Spratt BG (2003) Characterization of encapsulated and non-encapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 41 : 1623 1636.
18. Musser JM, Barenkamp SJ, Granoff DM Selander RK (1986) Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun 52 : 183 191.
19. National Committee for Clinical Laboratory Standards (2003) NCCLS Document M2-A8, Volume 23, no. 1. Performance Standards for Antimicrobial disk Susceptibility tests, Approved Standard, 8th edn. National Committee for Clinical Laboratory Standards, Villanova, PA.
20. Peltola H, Kaythy H, Sivonen A Makela PH (1977) Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100 000 vaccines 3 months to 5 years of age in Finland. Pediatrics 60 : 730 737.
21. Pennington TH (1993) Haemophilus species and clones. Rev Med Microbiol 4 : 50 58.
22. Pittman M (1931) Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 53 : 471 492.
23. Qin L, Watanabe H, Asoh N, Watanabe K, Oishi K, Mizota T nagatake T (2007) Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including β-lactamase-negative ampicillin-resistant strains. Epidemiol Infect 135 : 665 668.
24. Shen K, Antalis P, Gladitz J et al 2005) Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae. Infect Immun 73 : 3479 3491.
25. Tsang RSW, Mubareka S, Sill ML, Wylie J, Skinner S Law DKS (2006) Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era. J Clin Microbiol 44 : 1530 1535.
26. Tsang RSW, Sill ML, Skinner SJ, Law DKS, Zhou J Wylie J (2007) Characterization of invasive Haemophilus influenzae infections in Manitoba, Canada, from 2000 to 2006: invasive diseases due to non-type b strains. Clin Infect Dis 44 : 1611 1614.
27. Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, Broome CV The Haemophilus influenzae Study Group (1992) Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis 165 (suppl), S34 S35.
28. Zhanel GG, Palatnick L, Nichol KA, Low DE The Cross Study Group Hoban DJ (2003) Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian respiratory organisms susceptibility study, 1997-2002. Antimicrob Agents Chemother 47 : 1875 1881.
29. Zwahlen A, Kroll JS, Rubin LG Moxon ER (1989) The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap. Microb Pathog 7 : 225 235.